| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.86e-06 | 18 | 102 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | histone H4K16 acetyltransferase activity | 1.06e-05 | 9 | 102 | 3 | GO:0046972 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.20e-05 | 28 | 102 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.72e-05 | 37 | 102 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 1.77e-04 | 102 | 102 | 5 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.94e-04 | 104 | 102 | 5 | GO:0016407 | |
| GeneOntologyMolecularFunction | histone H4 acetyltransferase activity | 2.13e-04 | 23 | 102 | 3 | GO:0010485 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 4.54e-04 | 70 | 102 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 6.85e-04 | 78 | 102 | 4 | GO:0008080 | |
| GeneOntologyMolecularFunction | histone H4K8 acetyltransferase activity | 1.38e-03 | 11 | 102 | 2 | GO:0043996 | |
| GeneOntologyMolecularFunction | histone H4K5 acetyltransferase activity | 1.38e-03 | 11 | 102 | 2 | GO:0043995 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 1.40e-03 | 238 | 102 | 6 | GO:0016747 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.32e-05 | 10 | 102 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | dynein complex | 1.40e-04 | 54 | 102 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.67e-04 | 238 | 102 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | MSL complex | 2.34e-04 | 5 | 102 | 2 | GO:0072487 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.40e-04 | 25 | 102 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | motile cilium | 3.50e-04 | 355 | 102 | 8 | GO:0031514 | |
| Domain | Dynein_HC_stalk | 7.73e-07 | 14 | 101 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 7.73e-07 | 14 | 101 | 4 | IPR013602 | |
| Domain | DHC_N2 | 7.73e-07 | 14 | 101 | 4 | PF08393 | |
| Domain | MT | 7.73e-07 | 14 | 101 | 4 | PF12777 | |
| Domain | DHC_fam | 1.05e-06 | 15 | 101 | 4 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.05e-06 | 15 | 101 | 4 | IPR004273 | |
| Domain | Dynein_heavy | 1.05e-06 | 15 | 101 | 4 | PF03028 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.35e-05 | 14 | 101 | 3 | IPR024317 | |
| Domain | AAA_8 | 5.35e-05 | 14 | 101 | 3 | PF12780 | |
| Domain | ARM-type_fold | 9.27e-05 | 339 | 101 | 9 | IPR016024 | |
| Domain | PH_dom-like | DOCK9 ARHGEF12 LYST FRMD4B TIAM2 PPP4R3A ARHGEF40 RANBP3L CADPS ARHGEF4 | 1.04e-04 | 426 | 101 | 10 | IPR011993 |
| Domain | - | DOCK9 ARHGEF12 FRMD4B TIAM2 PPP4R3A ARHGEF40 RANBP3L CADPS ARHGEF4 | 2.70e-04 | 391 | 101 | 9 | 2.30.29.30 |
| Domain | MOZ_SAS | 2.86e-04 | 5 | 101 | 2 | PF01853 | |
| Domain | HAT_MYST-type | 2.86e-04 | 5 | 101 | 2 | IPR002717 | |
| Domain | MYST_HAT | 2.86e-04 | 5 | 101 | 2 | PS51726 | |
| Domain | DH_1 | 3.76e-04 | 63 | 101 | 4 | PS00741 | |
| Domain | Tudor-knot | 4.28e-04 | 6 | 101 | 2 | IPR025995 | |
| Domain | Tudor-knot | 4.28e-04 | 6 | 101 | 2 | PF11717 | |
| Domain | RhoGEF | 5.62e-04 | 70 | 101 | 4 | PF00621 | |
| Domain | DH_2 | 5.62e-04 | 70 | 101 | 4 | PS50010 | |
| Domain | DH-domain | 5.93e-04 | 71 | 101 | 4 | IPR000219 | |
| Domain | - | 5.93e-04 | 71 | 101 | 4 | 1.20.900.10 | |
| Domain | Somatotropin | 5.97e-04 | 7 | 101 | 2 | IPR001400 | |
| Domain | GDS_CDC24_CS | 1.22e-03 | 39 | 101 | 3 | IPR001331 | |
| Domain | DUF4599 | 1.84e-03 | 12 | 101 | 2 | PF15371 | |
| Domain | DUF4599 | 1.84e-03 | 12 | 101 | 2 | IPR027970 | |
| Domain | ATPase_dyneun-rel_AAA | 2.53e-03 | 14 | 101 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.53e-03 | 14 | 101 | 2 | PF07728 | |
| Domain | PH | 4.01e-03 | 278 | 101 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 4.08e-03 | 279 | 101 | 6 | PS50003 | |
| Domain | PH_domain | 4.16e-03 | 280 | 101 | 6 | IPR001849 | |
| Pubmed | Linkage of loci associated with two pigment mutations on mouse chromosome 13. | 8.75e-07 | 7 | 103 | 3 | 1682216 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | CUL4B RMND5B NAA15 DSP DDX42 SMC4 NAP1L4 VPS16 AP3B1 PPP4R3A CYFIP1 MSMO1 DNAH6 | 1.38e-06 | 847 | 103 | 13 | 35235311 |
| Pubmed | 5.05e-06 | 225 | 103 | 7 | 12168954 | ||
| Pubmed | Optimal bone fracture repair requires 24R,25-dihydroxyvitamin D3 and its effector molecule FAM57B2. | 8.69e-06 | 2 | 103 | 2 | 30010626 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 3584547 | ||
| Pubmed | 8.97e-06 | 14 | 103 | 3 | 9373155 | ||
| Pubmed | DOCK9 DDX42 SMC4 ARHGEF12 LRCH1 TIAM2 LRCH3 ARHGEF40 CYFIP1 FBXO28 ARHGEF4 BUB3 | 1.76e-05 | 916 | 103 | 12 | 32203420 | |
| Pubmed | 2.18e-05 | 282 | 103 | 7 | 23667531 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 10597135 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 27315375 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 30224647 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | USP34 NAA15 SMC4 NAP1L4 AP3B1 PPP4R3A CYFIP1 TMTC3 XPO5 PREP NGLY1 MAPK9 | 3.21e-05 | 974 | 103 | 12 | 28675297 |
| Pubmed | 3.66e-05 | 125 | 103 | 5 | 29467281 | ||
| Pubmed | A zonal organization of odorant receptor gene expression in the olfactory epithelium. | 5.19e-05 | 4 | 103 | 2 | 7683976 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 23300874 | ||
| Pubmed | Structural basis for MOF and MSL3 recruitment into the dosage compensation complex by MSL1. | 5.19e-05 | 4 | 103 | 2 | 21217699 | |
| Pubmed | The alveolar epithelium determines susceptibility to lung fibrosis in Hermansky-Pudlak syndrome. | 5.19e-05 | 4 | 103 | 2 | 23043085 | |
| Pubmed | Disruption of the MSL complex inhibits tumour maintenance by exacerbating chromosomal instability. | 5.19e-05 | 4 | 103 | 2 | 33837287 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 20805893 | ||
| Pubmed | 6.49e-05 | 335 | 103 | 7 | 15741177 | ||
| Pubmed | Sandy: a new mouse model for platelet storage pool deficiency. | 8.64e-05 | 5 | 103 | 2 | 1936982 | |
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 17182677 | ||
| Pubmed | MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2. | 8.64e-05 | 5 | 103 | 2 | 11965546 | |
| Pubmed | Mesenchymal dysplasia: a recessive mutation on chromosome 13 of the mouse. | 8.64e-05 | 5 | 103 | 2 | 8830098 | |
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 39056782 | ||
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 34171797 | ||
| Pubmed | 1.21e-04 | 638 | 103 | 9 | 33239621 | ||
| Pubmed | 1.29e-04 | 6 | 103 | 2 | 5367369 | ||
| Pubmed | 1.29e-04 | 6 | 103 | 2 | 37348029 | ||
| Pubmed | The beta2-adaptin clathrin adaptor interacts with the mitotic checkpoint kinase BubR1. | 1.29e-04 | 6 | 103 | 2 | 12419313 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CUL4B RMND5B IFT27 DYNC2H1 SMC4 AP3B1 PPP4R3A LRCH3 TBC1D32 CYFIP1 XPO5 BUB3 CHST3 | 1.45e-04 | 1321 | 103 | 13 | 27173435 |
| Pubmed | Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein. | 1.81e-04 | 7 | 103 | 2 | 11742995 | |
| Pubmed | Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. | 1.97e-04 | 38 | 103 | 3 | 11756498 | |
| Pubmed | 2.16e-04 | 407 | 103 | 7 | 12693553 | ||
| Pubmed | Saturation mutagenesis defines novel mouse models of severe spine deformity. | 2.40e-04 | 8 | 103 | 2 | 34142127 | |
| Pubmed | 2.40e-04 | 8 | 103 | 2 | 6781479 | ||
| Pubmed | 2.86e-04 | 43 | 103 | 3 | 12376548 | ||
| Pubmed | Confirmed rare copy number variants implicate novel genes in schizophrenia. | 3.08e-04 | 9 | 103 | 2 | 20298200 | |
| Pubmed | 3.08e-04 | 9 | 103 | 2 | 10193444 | ||
| Pubmed | 3.08e-04 | 9 | 103 | 2 | 10607900 | ||
| Pubmed | DSP DDX42 SMC4 PDE10A LYST SFMBT2 PPP4R4 RINT1 CAPRIN2 NGLY1 ARHGEF4 DNAH6 MYBPC1 | 3.39e-04 | 1442 | 103 | 13 | 35575683 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.47e-04 | 202 | 103 | 5 | 33005030 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 3.71e-04 | 588 | 103 | 8 | 38580884 | |
| Pubmed | A global genomic transcriptional code associated with CNS-expressed genes. | 3.79e-04 | 318 | 103 | 6 | 16919269 | |
| Pubmed | 3.85e-04 | 10 | 103 | 2 | 16227571 | ||
| Pubmed | Acetylation of HIV-1 integrase by p300 regulates viral integration. | 4.69e-04 | 11 | 103 | 2 | 16096645 | |
| Pubmed | 5.62e-04 | 12 | 103 | 2 | 28302748 | ||
| Pubmed | Sexual differentiation in the developing mouse brain: contributions of sex chromosome genes. | 5.62e-04 | 12 | 103 | 2 | 23210685 | |
| Pubmed | 5.62e-04 | 12 | 103 | 2 | 20018852 | ||
| Pubmed | H2B ubiquitylation promotes RNA Pol II processivity via PAF1 and pTEFb. | 5.62e-04 | 12 | 103 | 2 | 24837678 | |
| Pubmed | 5.84e-04 | 128 | 103 | 4 | 30995482 | ||
| Pubmed | 6.34e-04 | 638 | 103 | 8 | 31182584 | ||
| Pubmed | 6.63e-04 | 13 | 103 | 2 | 21626137 | ||
| Pubmed | MOF-associated complexes ensure stem cell identity and Xist repression. | 6.63e-04 | 13 | 103 | 2 | 24842875 | |
| Pubmed | Assessment of splice variant-specific functions of desmocollin 1 in the skin. | 6.63e-04 | 13 | 103 | 2 | 14673151 | |
| Pubmed | Evolution of odorant receptors expressed in mammalian testes. | 6.63e-04 | 13 | 103 | 2 | 11014824 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 7.19e-04 | 498 | 103 | 7 | 36634849 | |
| Pubmed | 7.37e-04 | 653 | 103 | 8 | 22586326 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 7.58e-04 | 363 | 103 | 6 | 14691545 | |
| Pubmed | Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR). | 7.64e-04 | 60 | 103 | 3 | 12787561 | |
| Pubmed | Proteomics strategy to identify substrates of LNX, a PDZ domain-containing E3 ubiquitin ligase. | 7.64e-04 | 60 | 103 | 3 | 22889411 | |
| Pubmed | 7.72e-04 | 14 | 103 | 2 | 7528109 | ||
| Pubmed | Mutations in mice that influence natural killer (NK) cell activity. | 7.72e-04 | 14 | 103 | 2 | 6971254 | |
| Pubmed | 7.72e-04 | 14 | 103 | 2 | 27551807 | ||
| Pubmed | 8.89e-04 | 15 | 103 | 2 | 6696991 | ||
| Pubmed | 9.03e-04 | 674 | 103 | 8 | 37196079 | ||
| Pubmed | Identification of novel Smad2 and Smad3 associated proteins in response to TGF-beta1. | 9.64e-04 | 65 | 103 | 3 | 18729074 | |
| Pubmed | 1.01e-03 | 16 | 103 | 2 | 24470103 | ||
| Pubmed | 1.01e-03 | 16 | 103 | 2 | 17696610 | ||
| Pubmed | 1.07e-03 | 259 | 103 | 5 | 9811942 | ||
| Pubmed | Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways. | 1.15e-03 | 17 | 103 | 2 | 12960231 | |
| Pubmed | 1.15e-03 | 17 | 103 | 2 | 12693554 | ||
| Pubmed | 1.15e-03 | 17 | 103 | 2 | 20479123 | ||
| Pubmed | 1.23e-03 | 399 | 103 | 6 | 37536630 | ||
| Pubmed | 1.24e-03 | 708 | 103 | 8 | 39231216 | ||
| Pubmed | 1.29e-03 | 18 | 103 | 2 | 28609438 | ||
| Pubmed | TCF and Groucho-related genes influence pituitary growth and development. | 1.29e-03 | 18 | 103 | 2 | 12907761 | |
| Pubmed | 1.29e-03 | 18 | 103 | 2 | 23534349 | ||
| Pubmed | Identification of host proteins required for HIV infection through a functional genomic screen. | 1.32e-03 | 272 | 103 | 5 | 18187620 | |
| Pubmed | 1.42e-03 | 560 | 103 | 7 | 35241646 | ||
| Pubmed | Genome-wide association with bone mass and geometry in the Framingham Heart Study. | 1.44e-03 | 19 | 103 | 2 | 17903296 | |
| Pubmed | 1.44e-03 | 19 | 103 | 2 | 9070936 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 1.55e-03 | 910 | 103 | 9 | 36736316 | |
| Pubmed | 1.59e-03 | 20 | 103 | 2 | 31911655 | ||
| Pubmed | 1.59e-03 | 20 | 103 | 2 | 31591574 | ||
| Pubmed | PP4R4/KIAA1622 forms a novel stable cytosolic complex with phosphoprotein phosphatase 4. | 1.59e-03 | 20 | 103 | 2 | 18715871 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 USP34 DOCK9 KAT6A LYST TIAM2 ARHGEF40 TXNRD3 ARHGEF4 NCK2 | 1.65e-03 | 1105 | 103 | 10 | 35748872 |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | 1.73e-03 | 925 | 103 | 9 | 28986522 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.76e-03 | 582 | 103 | 7 | 20467437 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.85e-03 | 934 | 103 | 9 | 33916271 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 1.96e-03 | 942 | 103 | 9 | 31073040 | |
| Pubmed | 2.25e-03 | 1153 | 103 | 10 | 29845934 | ||
| Pubmed | 2.28e-03 | 451 | 103 | 6 | 36168627 | ||
| Pubmed | 2.30e-03 | 24 | 103 | 2 | 21149574 | ||
| Pubmed | 2.36e-03 | 187 | 103 | 4 | 26460568 | ||
| Pubmed | Functional genomic landscape of cancer-intrinsic evasion of killing by T cells. | 2.44e-03 | 457 | 103 | 6 | 32968282 | |
| Pubmed | 2.49e-03 | 25 | 103 | 2 | 23132931 | ||
| Pubmed | Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms. | 2.49e-03 | 25 | 103 | 2 | 27340223 | |
| Pubmed | Genomic evolution of the placenta using co-option and duplication and divergence. | 2.69e-03 | 26 | 103 | 2 | 18340042 | |
| Pubmed | 2.90e-03 | 27 | 103 | 2 | 11156964 | ||
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.71e-04 | 66 | 76 | 4 | 722 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.77e-03 | 15 | 76 | 2 | 529 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 2.01e-03 | 16 | 76 | 2 | 66 | |
| GeneFamily | Dyneins, axonemal | 2.28e-03 | 17 | 76 | 2 | 536 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.28e-03 | 17 | 76 | 2 | 486 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 3.60e-07 | 195 | 103 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 3.60e-07 | 195 | 103 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.72e-06 | 169 | 103 | 6 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | droplet-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-06 | 182 | 103 | 6 | cfba75c1ffc39ac76db9e8e27394731942882b30 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-06 | 182 | 103 | 6 | d836bfdc298ecd3558a973e393a329eb8bd59d79 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-06 | 182 | 103 | 6 | 7e7c7a26460d3003cdf0c0ffb96208a566aa09a7 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.58e-06 | 185 | 103 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.58e-06 | 185 | 103 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.50e-06 | 191 | 103 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.83e-06 | 193 | 103 | 6 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.83e-06 | 193 | 103 | 6 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.01e-06 | 194 | 103 | 6 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.01e-06 | 194 | 103 | 6 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.01e-06 | 194 | 103 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 6.37e-06 | 196 | 103 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.56e-06 | 197 | 103 | 6 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.56e-06 | 197 | 103 | 6 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.56e-06 | 197 | 103 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.56e-06 | 197 | 103 | 6 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.15e-06 | 200 | 103 | 6 | cc906ff02fd335ff633b3b97afceb670494f910a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.15e-06 | 200 | 103 | 6 | 79e59ab31d3d3385b1b072dc75508af9546c2e1b | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 7.15e-06 | 200 | 103 | 6 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.15e-06 | 200 | 103 | 6 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Biopsy_IPF-Epithelial-Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 7.15e-06 | 200 | 103 | 6 | bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.15e-06 | 200 | 103 | 6 | 873def69bf55ccbfc944bc10c5afc06be019c312 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.68e-05 | 151 | 103 | 5 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | normal_Lung-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 3.64e-05 | 161 | 103 | 5 | 283012858e575c70d09950de53da041509f59bfa | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 3.86e-05 | 163 | 103 | 5 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.09e-05 | 165 | 103 | 5 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.09e-05 | 165 | 103 | 5 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | 3'_v3-GI_small-bowel-Mast-Mast_cell_granulo-myelo|GI_small-bowel / Manually curated celltypes from each tissue | 4.98e-05 | 172 | 103 | 5 | 3df11aefc09762fd1f94441324551178e030b249 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.41e-05 | 175 | 103 | 5 | 442f261a3b2c4d2523f7d4089178f8c79cac2f0f | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.41e-05 | 175 | 103 | 5 | 35fb7735dd3355476fe60404833cb60bd066bcf1 | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.56e-05 | 176 | 103 | 5 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.34e-05 | 181 | 103 | 5 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.51e-05 | 182 | 103 | 5 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 6.51e-05 | 182 | 103 | 5 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 6.68e-05 | 183 | 103 | 5 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.86e-05 | 184 | 103 | 5 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.86e-05 | 184 | 103 | 5 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 7.04e-05 | 185 | 103 | 5 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 7.22e-05 | 186 | 103 | 5 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.22e-05 | 186 | 103 | 5 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.22e-05 | 186 | 103 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.22e-05 | 186 | 103 | 5 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.22e-05 | 186 | 103 | 5 | 708c5edefe36c91df27cf53c1b5101fb2030cc5a | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.22e-05 | 186 | 103 | 5 | 029390c4aaf64e6bcd86124cd4a6dd2e6f3a374b | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.22e-05 | 186 | 103 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 7.40e-05 | 187 | 103 | 5 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.40e-05 | 187 | 103 | 5 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 7.59e-05 | 188 | 103 | 5 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 7.59e-05 | 188 | 103 | 5 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.59e-05 | 188 | 103 | 5 | 939790f133eac9c12d08db6ddb5f08f5107844e3 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.59e-05 | 188 | 103 | 5 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.59e-05 | 188 | 103 | 5 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.78e-05 | 189 | 103 | 5 | 9ab77c6fcb573854da5922412f53d2168bda6b58 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.78e-05 | 189 | 103 | 5 | 2aebea7a6c2f83112d7c504b742f2c04b92e459a | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.78e-05 | 189 | 103 | 5 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.78e-05 | 189 | 103 | 5 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 7.78e-05 | 189 | 103 | 5 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 7.78e-05 | 189 | 103 | 5 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 7.78e-05 | 189 | 103 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.98e-05 | 190 | 103 | 5 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.98e-05 | 190 | 103 | 5 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.98e-05 | 190 | 103 | 5 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.18e-05 | 191 | 103 | 5 | 8a5a2188b13ef4bbfd626a42565566708a751c1b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.18e-05 | 191 | 103 | 5 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 8.18e-05 | 191 | 103 | 5 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.18e-05 | 191 | 103 | 5 | e314dd8f1a841cab847ae3703bedfe1bc623ac61 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.18e-05 | 191 | 103 | 5 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.18e-05 | 191 | 103 | 5 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 8.18e-05 | 191 | 103 | 5 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | multiciliated|World / shred by cell class for turbinate | 8.38e-05 | 192 | 103 | 5 | 0f89ea0deb651ca11531c51ee94e0233608d22ea | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 8.38e-05 | 192 | 103 | 5 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 8.38e-05 | 192 | 103 | 5 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | COVID-19_Moderate-CD4+_T_activated|World / disease group, cell group and cell class | 8.59e-05 | 193 | 103 | 5 | c2a2a2c14a7085690262db5c2a70e38db67dee18 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.59e-05 | 193 | 103 | 5 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 8.59e-05 | 193 | 103 | 5 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-05 | 193 | 103 | 5 | ca7c0a4ceb05bced90f6cdc53d278e547fb241e9 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.59e-05 | 193 | 103 | 5 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.59e-05 | 193 | 103 | 5 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.59e-05 | 193 | 103 | 5 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 8.59e-05 | 193 | 103 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 8.59e-05 | 193 | 103 | 5 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.80e-05 | 194 | 103 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 8.80e-05 | 194 | 103 | 5 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.80e-05 | 194 | 103 | 5 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.80e-05 | 194 | 103 | 5 | b0477583301dc6d9767b667bd2f8f94fbfaa6f81 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.80e-05 | 194 | 103 | 5 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 8.80e-05 | 194 | 103 | 5 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.01e-05 | 195 | 103 | 5 | d8bf15aa7cdbc5f29b58e1e6cff76c257f0ea12e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.01e-05 | 195 | 103 | 5 | 0fbba312e9ba9b70b4b814b67b6eb1f6544aaf6d | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 9.01e-05 | 195 | 103 | 5 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.01e-05 | 195 | 103 | 5 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.01e-05 | 195 | 103 | 5 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.01e-05 | 195 | 103 | 5 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.01e-05 | 195 | 103 | 5 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.01e-05 | 195 | 103 | 5 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.01e-05 | 195 | 103 | 5 | e7f069f557a59ee7b502ff82ad4c9f47fa619ba8 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 9.23e-05 | 196 | 103 | 5 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| Disease | forced expiratory volume, response to bronchodilator | 9.72e-05 | 445 | 95 | 8 | EFO_0004314, GO_0097366 | |
| Disease | cortical surface area measurement | USP34 CTTNBP2 BAZ2B DOCK9 ARHGEF12 CNTLN LRCH1 DNAH7 FRMD4B PPP4R3A CSGALNACT2 CADPS TLE4 MLH1 | 1.01e-04 | 1345 | 95 | 14 | EFO_0010736 |
| Disease | VACTERL association (implicated_via_orthology) | 1.53e-04 | 6 | 95 | 2 | DOID:14679 (implicated_via_orthology) | |
| Disease | susceptibility to measles measurement | 5.35e-04 | 49 | 95 | 3 | EFO_0008414 | |
| Disease | colorectal cancer (is_implicated_in) | 6.42e-04 | 121 | 95 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 1.05e-03 | 15 | 95 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | body surface area | 1.12e-03 | 643 | 95 | 8 | EFO_0022196 | |
| Disease | Feeding difficulties | 1.52e-03 | 18 | 95 | 2 | C0232466 | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 1.69e-03 | 19 | 95 | 2 | EFO_0002609, GO_0031427 | |
| Disease | behavioural disinhibition measurement | 1.85e-03 | 75 | 95 | 3 | EFO_0006946 | |
| Disease | schizophrenia (is_implicated_in) | 2.07e-03 | 78 | 95 | 3 | DOID:5419 (is_implicated_in) | |
| Disease | QRS duration, response to sulfonylurea | 2.48e-03 | 23 | 95 | 2 | EFO_0005055, EFO_0007922 | |
| Disease | airway responsiveness measurement | 2.70e-03 | 24 | 95 | 2 | EFO_0006897 | |
| Disease | TEMPS-A questionnaire | 2.93e-03 | 25 | 95 | 2 | EFO_0004783 | |
| Disease | platelet component distribution width | 3.05e-03 | 755 | 95 | 8 | EFO_0007984 | |
| Disease | cortical thickness | CTTNBP2 DOCK9 ARHGEF12 LRCH1 FRMD4B PPP4R3A ARHGEF40 XPO5 CADPS CFAP57 | 3.11e-03 | 1113 | 95 | 10 | EFO_0004840 |
| Disease | response to methotrexate, drug-induced liver injury | 3.17e-03 | 26 | 95 | 2 | EFO_0004228, GO_0031427 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KHLLAKVQQEACAQY | 56 | Q8TER5 | |
| QKLYNELHICFETTK | 381 | Q9NXG0 | |
| YICIAVFKHLQQDIL | 1191 | Q96NH3 | |
| KQIQKHLDYITQACL | 1746 | Q9UIF8 | |
| FFLFDHQLIYCKKDL | 521 | Q9NR80 | |
| FKCHRLKENNIEQIY | 221 | O43684 | |
| KLLYKQQLEECRHQE | 3186 | Q96M86 | |
| AAYLQHLCFGDNKIK | 571 | Q9UQB3 | |
| KKAADHCRQILNYVN | 961 | Q9NZN5 | |
| LIHKNYRKLCNLLVD | 221 | O00203 | |
| LKHKQSCAVENFYIL | 51 | Q6UY27 | |
| EKCEVVIQHFNGKYL | 191 | Q6XE24 | |
| CANYLVKDLIAEILH | 306 | O75747 | |
| NEGYIKKLLELFHVC | 166 | Q6IN85 | |
| KCFKVLLFNHFCIQL | 96 | Q15800 | |
| LGIKKFEHQLLYNAC | 281 | Q9ULU8 | |
| VLDFCYHLLKVQKHD | 1176 | Q7L576 | |
| YRELVLLKCVNHKNI | 71 | P45984 | |
| KQLQVRCAHIEAKFY | 71 | Q99733 | |
| QICKVVLDHFEKQYS | 16 | Q9H649 | |
| VHIFKYLNIQACKIA | 266 | Q96II8 | |
| NEKISKQLHLCYNIV | 486 | Q96IV0 | |
| KHFKVQLVDNVYCIG | 331 | O43639 | |
| HLFYKKCAQLTVNLT | 191 | P54760 | |
| HKIYCQNLCLLAKLF | 256 | Q9H7Z6 | |
| KRFKTDLHNCVAYIQ | 1051 | Q96MR6 | |
| YEHFRKELVNAQCAK | 81 | Q9Y3C7 | |
| ICINDLITEYNKQHK | 611 | P50747 | |
| QIHAECKRFGKAYNL | 341 | Q86XP3 | |
| FHLCKILKYEVDLND | 656 | Q9HCI6 | |
| RCALFQVDHKNKELY | 286 | Q9Y233 | |
| NVHYIPAEKNVDLCK | 241 | Q8N5Y2 | |
| VHIFKYLSIQACQIK | 281 | Q9Y2L9 | |
| LYELLKCNHNIKEAI | 251 | Q7Z3K6 | |
| QKIYHFFCEILAVLK | 171 | Q96R45 | |
| LCKLVLAVDHYNIFS | 116 | P48146 | |
| NALFKRILRCYEHKQ | 11 | Q9BXJ9 | |
| QKIYHFFCEILAVLK | 171 | O95047 | |
| FQKQCIKLHICQYFL | 171 | Q9H0J9 | |
| IKLHICQYFLQGECK | 176 | Q9H0J9 | |
| IVVVLCLYFKIHNAL | 16 | Q8N5W8 | |
| QRYIKELCNLFEAHK | 306 | Q3SYC2 | |
| ELCNLFEAHKLKFNI | 311 | Q3SYC2 | |
| SNFLVLCYLHDVKNI | 346 | P48147 | |
| KSVILECLYHQNDKQ | 696 | Q92794 | |
| LFFLNAKACVHKGQI | 156 | Q9Y2L6 | |
| CKQAIILKQVAHFYN | 611 | Q8NCM8 | |
| CIHQDKKIHLTVVYF | 296 | Q8N6G5 | |
| KCHTYTLQEFKAAQV | 336 | Q9C0G6 | |
| CLAKQFHQLYREKVE | 166 | Q9BW83 | |
| KVFDVYLCFLQKHQS | 1431 | Q9BZ29 | |
| FLCDIYHQNRLSKKE | 301 | Q07973 | |
| CYFKHTLQQKVFILF | 6 | Q9P109 | |
| SLQDYIVHQLALCLK | 1131 | Q8WZ74 | |
| FCYIKILHQLKRCQN | 216 | P51685 | |
| EEIFQYVCHILRKAK | 436 | Q9P0X4 | |
| KCIDVHLKENAAYFQ | 366 | P15924 | |
| KKLLYGLCFFHALVQ | 3576 | Q8WXX0 | |
| FLKVERYHNLCQKQV | 106 | Q9NVF7 | |
| ACHILAIYFLLNKKL | 371 | P57058 | |
| YIENGLICLKHKIRN | 121 | Q6IMN6 | |
| IHQVLIKQKCIVGFY | 1861 | Q99698 | |
| VIHSYLCKGLQEKFF | 26 | Q96PG1 | |
| FILHVFQGNALKLKC | 931 | Q6ZTR5 | |
| FTTQFLKLHCLQKLY | 166 | H0Y7S4 | |
| LYKQLRQICEDHIKA | 256 | Q13620 | |
| DNYLKLLKCRIIHNN | 211 | P01236 | |
| LNKLCLTVYQLHALQ | 196 | Q9GZN7 | |
| DQHLRFLEFYKKLCT | 331 | Q6NUP7 | |
| INCVTFALKYRHKQV | 936 | Q14C87 | |
| LNQKTHICYEAKFSI | 26 | A0A494BZU4 | |
| LDIRCSYIHVKQIFK | 31 | Q86YW0 | |
| SKCFEDHLEQKYVQL | 486 | Q6ZUB0 | |
| YSVKKCIFLLFINHR | 251 | P40692 | |
| ILCGKHVDYKNVQLL | 66 | Q9Y3D5 | |
| VLKQLFLCDLYVLEH | 191 | Q7LGC8 | |
| EKYCQLKNAHLVVIN | 206 | Q8IUN9 | |
| VTYKENIAKCQHIFV | 341 | O95436 | |
| CFYHQKDIKLENLII | 116 | Q8N1K5 | |
| SKCFEDHLEQKYVQL | 486 | P0C874 | |
| GIHFKFCVENIRKYL | 666 | Q96HI0 | |
| CKESFTQKNILLVHY | 1501 | Q86UP3 | |
| CEKAFSQKSYLIIHQ | 491 | P17025 | |
| QLLYDCHICERKFKN | 401 | Q9P243 | |
| CKESFTQKNILLVHY | 1196 | Q9C0A1 | |
| YSGFCANHIKVQKVL | 1201 | Q8IVF5 | |
| YFKHIKEACIVLNLN | 726 | Q6NUQ1 | |
| HFVKLLKDIIICFLN | 831 | Q9H5L6 | |
| LDKVLQKFLTYGQHC | 11 | Q96G75 | |
| FLQAQYHSLKLECEK | 41 | Q04727 | |
| EHNVLKINCKLFIFN | 296 | Q86VV4 | |
| QFCKHQELETLKDLY | 606 | Q9H269 | |
| KLCHQIERVKVAFYA | 876 | Q5VUG0 | |
| LVEKHYVFLKRLCQV | 311 | Q9HAV4 | |
| LENEIFRKKNHVCQY | 311 | Q9NTJ3 | |
| HFYERCFKIAQLIKI | 161 | Q8NA56 | |
| FVCLGKILIQYKQQH | 171 | Q71RH2 | |
| YAKIICNKFDHDRVI | 566 | Q86VQ6 | |
| KCNVQFNLLDPLKYH | 241 | Q8ND82 | |
| KEYKHLEIFNQVVCA | 51 | Q70CQ2 | |
| HNLCVVYFEEKDLLK | 776 | Q6ZXV5 | |
| LLVFQLVQACYHKLD | 76 | Q6XPR3 | |
| QRKIFQCDEYVKFLH | 141 | Q5JVG8 | |
| LLNILYCVKITNFQH | 101 | Q9NYW5 | |
| KIIDCGKAFYQNRHL | 521 | Q86TJ5 | |
| TKYIFEHKGCQRILF | 296 | Q00872 |